Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature

• Publication date

  2007-04-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature05690PMID 17344859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A PANorama of PAX genes in cancer and development

  2006cited by this paper
• Common deletion polymorphisms in the human genome

  2006cited by this paper
• Foxp1 is an essential transcriptional regulator of B cell development

  2006cited by this paper
• dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53

  2005cited by this paper
• ETV6: a versatile player in leukemogenesis.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

  2005cited by this paper
• FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations

  2005cited by this paper
• Transcriptional control of early B cell development.

  2004cited by this paper
• Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays

  2004cited by this paper
• Circular binary segmentation for the analysis of array-based DNA copy number data.

  2004cited by this paper
• Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.

  2004cited by this paper
• dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data

  2004cited by this paper
• PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13)

  2003cited by this paper
• Classification of pediatric acute lymphoblastic leukemia by gene expression profiling.

  2003cited by this paper
• Origins of chromosome translocations in childhood leukaemia

  2003cited by this paper
• Activation of the Early B-Cell-Specific mb-1 (Ig-α) Gene by Pax-5 Is Dependent on an Unmethylated Ets Binding Site

  2003cited by this paper
• Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein.

  2003cited by this paper
• Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators

  2002cited by this paper
• The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.

  2001cited by this paper
• Structural studies of Ets-1/Pax5 complex formation on DNA.

  2001cited by this paper
• Deletion of chromosomal region 13q14.3 in childhood acute lymphoblastic leukemia

  2001cited by this paper
• Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis.

  2000cited by this paper
• Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.

  2000cited by this paper
• Independent regulation of the two Pax5 alleles during B-cell development

  1999cited by this paper
• Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.

  1999cited by this paper
• Commitment to the B-lymphoid lineage depends on the transcription factor Pax5

  1999cited by this paper
• Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia

  1999cited by this paper
• Commitment to the B-lymphoid lineage depends on the transcription factor Pax5

  1999cited by this paper
• Identification of BSAP (Pax‐5) target genes in early B‐cell development by loss‐ and gain‐of‐function experiments

  1998cited by this paper
• Regulation of mouse CD72 gene expression during B lymphocyte development.

  1998cited by this paper
• Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.

  1996cited by this paper
• The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.

  1996cited by this paper
• Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.

  1995cited by this paper
• Failure of B-cell differentiation in mice lacking the transcription factor EBF

  1995cited by this paper
• DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5)

  1995cited by this paper
• Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features.

  1995cited by this paper
• The Ikaros gene is required for the development of all lymphoid lineages.

  1994cited by this paper

• Epigenetic, Genetic, and Functional Germline Alterations of PAX Genes in Human Pathology: A Comprehensive Update.

  2026cites this paper
• Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients

  2025cites this paper
• The Double-Faced t(12;21) in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Patients: Seven Years Experience at a Tertiary Center.

  2025cites this paper
• Mechanistic understanding of Wiskott–Aldrich syndrome protein (WASp)-mediated epigenetic regulation of T helper cell differentiation in acute leukemia

  2025cites this paper
• A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia

  2025cites this paper
• Loss of Heterozygosity in Pediatric Acute Lymphoblastic Leukemia and Its Prognostic Impact: A Retrospective Study

  2025cites this paper
• Flicking the switch for B-cell development

  2025cites this paper
• Genetics of B-Cell Acute Lymphoblastic Leukemia (B-ALL): Recent Updates and Indian Perspective

  2025cites this paper
• The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjögren’s syndrome

  2025cites this paper
• Genomic determinants of therapy response in ETV6::RUNX1 leukemia

  2025cites this paper
• PD-1 Expression Promotes Immune Evasion in B-ALL

  2025cites this paper
• Insights into germline predisposition to pediatric lymphoid malignancies

  2025cites this paper
• LEF1 Intragenic Deletion Induces a Dominant-Negative isoform and unveils a Wnt/β3-Catenin Vulnerability in T-ALL.

  2025cites this paper
• The hematopoietic stem cell MYB enhancer is essential for and recurrently amplified during T cell leukemogenesis

  2025cites this paper
• Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia — a polish paediatric population treated according to ALL-IC BFM 2009 protocol

  2025cites this paper
• Chromatin Accessibility Shapes Developmental-Specific Lineage Plasticity in Hematopoiesis

  2025cites this paper
• BTB domain and CNC homolog 2: A master regulator that controls immune response and cancer progression.

  2025cites this paper
• Two‐way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3

  2025cites this paper
• H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia

  2025cites this paper
• PAX Family, Master Regulator in Cancer

  2025cites this paper
• Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia

  2025cites this paper
• High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients

  2025cites this paper
• Investigating the causes of childhood acute lymphoblastic leukemia through mutational epidemiology.

  2025cites this paper
• Optical Genome Mapping in Pediatric Hematologic Malignancies: High Diagnostic Yield and Unique Insights Across Leukemia Subtypes.

  2025cites this paper
• "A novel approach to understanding the role of TCF3 mutations in childhood B-cell precursor acute lymphoblastic leukemia"

  2025cites this paper
• Genomics of T-lymphoblastic leukemia/lymphoma: 2023 SH/EAHP workshop proceedings.

  2025cites this paper
• IGH :: IL3 ‐Rearranged B‐Cell Precursor Acute Lymphoblastic Leukemia With Hypereosinophilia in a Child With a Novel PAX5 Germline Variant

  2025cites this paper
• Application of Targeted RNA‐Sequencing in High‐Risk B‐Cell Acute Lymphoblastic Leukemia (B‐ALL): Identifying Fusions, IKZF1 Deletions, and CRLF2 Expression in an Indian Cohort

  2025cites this paper
• A Comprehensive Mini Review of Clinical Biochemical Parameters in the Diagnosis of Acute Lymphoblastic Leukemia in Children

  2025cites this paper
• A characteristic gene expression profile regulated by ACIN1::NUTM1 fusion in a newly identified infant leukaemic cell line and an ACIN1::NUTM1‐inducible model

  2025cites this paper
• Error Reduction in Leukemia Machine Learning Classification With Conformal Prediction

  2025cites this paper
• B-lineage commitment is dependent on a reversible epigenetic switch

  2025cites this paper
• Novel Therapeutic Approaches in Pediatric Acute Lymphoblastic Leukemia

  2025influential citation
• IKAROS Gene Regulatory Network Reveal ERG as a Vulnerability in B-cell Acute Lymphoblastic Leukemia

  2025cites this paper
• Acquired resistance to molecularly targeted therapies for cancer

  2025cites this paper
• Treatment-related mutagenic processes in acute lymphoblastic leukemia

  2025cites this paper
• Comparative Profiling of Regulatory Modules as a Tool for Identifying the Transcription Factor Network Linked to Leukemogenesis.

  2025cites this paper
• A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation

  2025cites this paper
• A foundation model of transcription across human cell types

  2025cites this paper
• Immune training enhances anti-viral responses and improves outcomes in Pax5−/+ mice susceptible to chronic infection

  2025cites this paper
• CYTOMEGALOVIRUS INFECTION AMONG LEUKEMIC CHILDREN IN SANA’A CITY, YEMEN

  2025cites this paper
• Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients

  2025cites this paper
• Overt and covert genetic causes of pediatric acute lymphoblastic leukemia

  2025cites this paper
• Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-Cell Acute Lymphoblastic Leukemia.

  2025cites this paper
• Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo

  2025cites this paper
• LINEAGE SWITCH - CASE REPORT SHOWING THERAPY RELATED CLONAL SELECTION AS THE ETIOLOGY

  2025cites this paper
• Enhanced detection of splice altering variants in hematologic malignancies using targeted RNA-seq data.

  2025cites this paper
• Structural birth defects and leukemia risk in children with Down syndrome

  2025cites this paper
• Preliminary insights into methylation patterns in Agent Orange exposed thyroid cancers: a pilot study.

  2025cites this paper
• Single-cell sequencing revealed the recurrence causes of ETV6::RUNX1 fusion-positive B-ALL in children.

  2025cites this paper
• IKZF1 Variants Predicted Poor Outcomes in Acute Myeloid Leukemia Patients with CEBPA bZIP In-Frame Mutations

  2025cites this paper
• Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report

  2024cites this paper
• High-throughput Sequencing Reveals that BCR and TCR Repertoires as Potential Prognostic Biomarkers for Pediatric Patients with B-ALL

  2024cites this paper
• PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma

  2024cites this paper
• IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line

  2024cites this paper
• Unraveling Copy Number Alterations in Pediatric B-Cell Acute Lymphoblastic Leukemia: Correlation with Induction Phase Remission Using MLPA

  2024cites this paper
• Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer

  2024cites this paper
• Early B-Cell Factor 1: An Archetype for a Lineage-Restricted Transcription Factor Linking Development to Disease.

  2024cites this paper
• Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities

  2024cites this paper
• Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia

  2024cites this paper
• Linker histone H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape

  2024cites this paper
• Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

  2024cites this paper
• Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemia

  2024cites this paper
• Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation

  2024cites this paper
• Identification of a novel MEF2C::SS18L1 fusion in childhood acute B-lymphoblastic leukemia

  2024cites this paper
• GET: a foundation model of transcription across human cell types

  2024cites this paper
• Multifaceted roles of IKZF1 gene, perspectives from bench to bedside

  2024influential citation
• The impact of comparative genomic hybridization/single‐nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia

  2024cites this paper
• The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers.

  2024cites this paper
• A multiomic characterization of the leukemia cell line REH using short- and long-read sequencing

  2024cites this paper
• microRNA expression profiling of bone marrow and peripheral blood samples in children with B-cell acute lymphoblastic leukemia: MiR-223-3p, miR-363-3p, and miR-708-5p as potential biomarkers

  2024cites this paper
• Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia

  2024cites this paper
• Cytogenomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals TCR rearrangements as predictive factors for exceptional prognosis

  2024cites this paper
• New clinical treatment plan for acute lymphoblastic leukemia after whole genome sequencing: An update of the development of new technologies for genome editing

  2024cites this paper
• Overexpression of PTPN21 promotes proliferation of EGF-stimulated acute lymphoblastic leukemia cells via the MAPK signaling pathways

  2024cites this paper
• Research Progress of PAX5 Gene in Children with Acute Lymphoblastic Leukemia

  2024cites this paper
• A Comparative Study of B Cell Blast Isolation Methods from Bone Marrow Aspirates of Pediatric Leukemia Patients

  2024cites this paper
• Eficácia e Segurança do Blinatumomabe no Tratamento da Leucemia Linfoblástica Aguda: Revisão Sistemática da Literatura

  2024cites this paper
• ZMIZ1::ABL1 Fusion: An Uncommon Molecular Event With Clinical Implications in Pediatric Cancer.

  2024cites this paper
• Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia

  2024cites this paper
• A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia

  2024cites this paper
• Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome

  2024cites this paper
• Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia

  2024cites this paper
• Hematological and Biochemical Characteristics Associated with Cytogenetic Findern Alterations in Adult Patients with Acute Lymphoblastic Leukemia (ALL) from the Northern Region of Brazil

  2024cites this paper
• ITGAM is a critical gene in ischemic stroke

  2024cites this paper
• Chromosomal Variations and Clinical Features of Acute Lymphoblastic Leukemia in the North Indian Population: A Cross-Sectional Study

  2024cites this paper
• Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance

  2024cites this paper
• Case report: A familial B-acute lymphoblastic leukemia associated with a new germline pathogenic variant in PAX5. The first report in Mexico

  2024cites this paper
• IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia

  2024cites this paper
• PAX5 Alterations in a Consecutive Childhood B-Cell Acute Lymphoblastic Leukemia Cohort Treated Using the ALL IC-BFM 2009 Protocol

  2024influential citation
• Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

  2024cites this paper
• Bone marrow inflammation in haematological malignancies

  2024cites this paper
• The IKAROS Transcription Factor Gene IKZF1 as a Critical Regulator in the Pathogenesis of Childhood Acute Lymphoblastic Leukemia: Insights from a Bangladeshi Population

  2024cites this paper
• AIOLOS-Associated Inborn Errors of Immunity

  2024cites this paper
• Somatic variant profiling of a thymoma in Good Syndrome

  2024cites this paper
• The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies

  2024cites this paper
• ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

  2024cites this paper
• Acute lymphoblastic leukaemia

  2024cites this paper
• Data‐driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes

  2024cites this paper
• The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia.

  2024cites this paper